DXCM - Dexcom Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - DXCM (1093557)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
82 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-05-15
DXCMDolan Matthew VincentEVP Strategy, Corporate DevS - Sale$126.58-2,42340,075-6%-$306,703
2024-04-30
DXCMBrown Michael JonEVP GCS - Sale$126.25-62968,212-1%-$79,411
2024-04-15
DXCMDolan Matthew VincentEVP Strategy, Corporate DevS - Sale$137.81-1,99042,377-4%-$274,242
2024-04-08
DXCMSayer Kevin RPres CEO, COBS - Sale$138.30-49,633283,893-15%-$6,864,136
2024-03-28
DXCMBrown Michael JonEVP GCS - Sale$140.04-2,62468,682-4%-$367,472
2024-03-25
DXCMStern SadieEVP Chief HRS - Sale$140.00-4,13776,304-5%-$579,180
2024-03-15
DXCMDolan Matthew VincentEVP Strategy, Corp DevS - Sale$130.21-4,20344,367-9%-$547,259
2024-03-12
DXCMSylvain Jereme MEVP CFOS - Sale$134.41-11,66185,534-12%-$1,567,363
2024-03-12
DXCMStern SadieEVP Chief HRS - Sale$133.61-20,32180,441-20%-$2,715,006
2024-03-12
DXCMSayer Kevin RPres CEO, COBS - Sale$133.36-81,007333,526-20%-$10,802,803
2024-03-12
DXCMLeach Jacob StevenEVP COOS - Sale$134.41-14,639313,473-4%-$1,967,638
2024-03-12
DXCMLawver Teri LEVP Chief Commercial OfficerS - Sale$134.41-4,76466,641-7%-$640,333
2024-03-12
DXCMDolan Matthew VincentEVP Strategy, CorporateS - Sale$134.41-6,71048,570-12%-$901,896
2024-03-12
DXCMBrown Michael JonEVP GCS - Sale$134.41-8,79971,306-11%-$1,182,680
2024-02-20
DXCMSylvain Jereme MEVP CFOS - Sale$116.73-3,36371,142-5%-$392,563
2024-01-16
DXCMStern SadieEVP Chief HRS - Sale$123.64-2,90279,051-4%-$358,788
2024-01-16
DXCMSylvain Jereme MEVP CFOS - Sale$123.64-2,73474,505-4%-$338,018
2024-01-16
DXCMSayer Kevin RPres, CEO, COBS - Sale$123.64-37,325362,841-9%-$4,614,669
2024-01-16
DXCMLeach Jacob StevenEVP COOS - Sale$123.64-3,978309,795-1%-$491,819
2024-01-16
DXCMAltman Steven RDirS - Sale$122.87-1,56856,017-3%-$192,652
2023-12-15
DXCMAugustinos NicholasDirS - Sale$123.02-3,97637,083-10%-$489,128
2023-12-15
DXCMAltman Steven RDirS - Sale$122.77-2,00057,585-3%-$245,548
2023-12-12
DXCMAltman Steven RDirS - Sale$120.00-3,00059,585-5%-$360,004
2023-12-11
DXCMStern SadieEVP Chief HR OffiS - Sale$117.66-39276,008-1%-$46,123
2023-12-01
DXCMBrown Michael JonEVP GCS - Sale$114.56-3,61258,394-6%-$413,774
2023-11-09
DXCMNaganathan GirishEVP CTOS - Sale$93.27-2,72547,725-5%-$254,161
2023-11-24
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$110.80-411124,7750%-$45,539
2023-11-22
DXCMStern SadieEVP Chief HR OffiS - Sale$110.00-1,17676,400-2%-$129,360
2023-11-15
DXCMAltman Steven RDirS - Sale$101.26-1,00062,585-2%-$101,256
2023-11-08
DXCMRegan Barry J.EVP OperationsS - Sale$95.22-2,01964,250-3%-$192,249
2023-10-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$85.75-411125,1860%-$35,243
2023-10-16
DXCMAltman Steven RDirS - Sale$77.58-1,00063,585-2%-$77,580
2023-09-22
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$88.40-411125,5970%-$36,332
2023-09-15
DXCMAltman Steven RDirS - Sale$101.50-1,00064,585-2%-$101,495
2023-09-12
DXCMHeller Bridgette PDirS - Sale$106.56-60023,731-2%-$63,936
2023-09-01
DXCMDolan Matthew VincentSVP Corporate Strategy-DevelopS - Sale$102.32-5633,5690%-$5,730
2023-08-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$107.03-411126,0080%-$43,989
2023-08-22
DXCMSylvain Jereme MEVP CFOS - Sale$104.38-1,84472,867-2%-$192,477
2023-08-09
DXCMStern SadieEVP Chief HR OffiS - Sale$110.71-39281,6820%-$43,398
2023-07-24
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$130.58-412126,4190%-$53,799
2023-07-14
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$136.00-5,031126,831-4%-$684,216
2023-07-10
DXCMStern SadieEVP Chief HR OffiS - Sale$128.05-39282,0740%-$50,196
2023-07-10
DXCMRegan Barry J.EVP OperationsS - Sale$128.05-1,98966,269-3%-$254,691
2023-06-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$125.92-412131,8620%-$51,879
2023-06-15
DXCMSelvaraj Shelly RamasamySVP CIOS - Sale$130.00-2,11550,390-4%-$274,953
2023-06-09
DXCMStern SadieEVP Chief HR OffiS - Sale$121.31-39382,4660%-$47,675
2023-05-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$118.65-412132,2740%-$48,884
2023-05-22
DXCMSylvain Jereme MEVP CFOS - Sale$117.58-2,40074,711-3%-$282,192
2023-05-09
DXCMStern SadieEVP Chief HR OffiS - Sale$120.19-39382,8590%-$47,235
2023-04-27
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$126.00-5,031132,686-4%-$633,906
2023-04-24
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$124.68-412137,7170%-$51,368
2023-04-20
DXCMLeach Jacob StevenEVP CTOS - Sale$125.00-30,764306,909-9%-$3,845,500
2023-04-20
DXCMRegan Barry J.EVP OperationsS - Sale$124.50-2,21468,258-3%-$275,643
2023-04-20
DXCMSelvaraj Shelly RamasamySVP CIOS - Sale$125.00-2,00752,505-4%-$250,875
2023-04-17
DXCMFlynn Paul REVP Global RevenueS - Sale$120.00-2,78152,112-5%-$333,720
2023-04-10
DXCMStern SadieEVP Chief HR OffiS - Sale$112.35-39383,2520%-$44,154
2023-04-03
DXCMSayer Kevin RPres CEO, COB ofS - Sale$114.46-20,812327,457-6%-$2,382,069
2023-04-03
DXCMBrown Michael JonEVP GCS - Sale$114.48-3,61261,870-6%-$413,490
2023-03-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$116.40-5,442138,129-4%-$633,449
2023-03-16
DXCMDolan Matthew VincentSVP Corporate Strategy-DevelopS - Sale$115.00-2,30333,569-6%-$264,845
2023-03-14
DXCMStern SadieEVP Chief HR OffiS - Sale$111.86-39383,6450%-$43,961
2023-03-13
DXCMRegan Barry J.EVP OperationsS - Sale$106.27-2,01070,472-3%-$213,603
2023-03-13
DXCMFlynn Paul REVP Global RevenueS - Sale$106.27-2,78254,893-5%-$295,643
2023-03-13
DXCMDolan Matthew VincentSVP Corporate Strategy-DevelopS - Sale$106.27-6,22935,872-15%-$661,956
2023-03-06
DXCMLeach Jacob StevenEVP CTOS - Sale$114.74-18,144328,385-5%-$2,081,822
2023-03-06
DXCMDolan Matthew VincentSVP Corporate Strategy-DevelopS - Sale$114.40-22626,536-1%-$25,854
2023-03-01
DXCMSayer Kevin RPres CEO, COB ofS - Sale$109.94-38,464331,337-10%-$4,228,611
2023-02-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$111.64-412136,4640%-$45,996
2023-02-22
DXCMSylvain Jereme MEVP CFOS - Sale$114.54-2,40064,837-4%-$274,896
2023-01-30
DXCMRegan Barry J.EVP OperationsS - Sale$106.12-2,21359,386-4%-$234,844
2023-01-30
DXCMSayer Kevin RPres CEO, COB ofS - Sale$106.15-56,844369,801-13%-$6,034,123
2023-01-20
DXCMSayer Kevin RPres CEO, COB ofS - Sale$105.75-45,607426,645-10%-$4,822,872
2023-01-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$107.86-412136,8760%-$44,438
2022-12-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$112.57-412137,2880%-$46,379
2022-12-08
DXCMFlynn Paul REVP Global RevenueS - Sale$123.50-8,98855,744-14%-$1,110,018
2022-11-21
DXCMSylvain Jereme MEVP CFOS - Sale$112.62-2,40067,237-3%-$270,288
2022-09-01
DXCMDolan Matthew VincentSVP Corporate Strategy-DevelopS - Sale$81.63-526,5360%-$408
2022-08-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$84.21-1,000137,700-1%-$84,210
2022-07-25
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$83.07-1,000138,700-1%-$83,070
2022-06-23
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$72.55-1,000139,700-1%-$72,550
2022-06-06
DXCMSylvain Jereme MEVP CFOS - Sale$301.57-60017,408-3%-$180,942
2022-05-24
DXCMPacelli Steven RobertEVP MD Dexcom VS - Sale$296.33-25035,175-1%-$74,083

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top